Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Maxcyte (MXCT) Return on Capital Employed (2021 - 2026)

Maxcyte has reported Return on Capital Employed over the past 5 years, most recently at 4.84% for Q4 2025.

  • Quarterly Return on Capital Employed fell 108.0% to 4.84% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4.84% through Dec 2025, down 108.0% year-over-year, with the annual reading at 4.53% for FY2025, 93.0% down from the prior year.
  • Return on Capital Employed was 4.84% for Q4 2025 at Maxcyte, up from 5.47% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 0.66% in Q1 2022 and troughed at 18.61% in Q3 2023.
  • The 5-year median for Return on Capital Employed is 3.97% (2021), against an average of 5.81%.
  • Year-over-year, Return on Capital Employed plummeted -1441bps in 2023 and then soared 1600bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 1.51% in 2021, then plummeted by -568bps to 10.09% in 2022, then soared by 68bps to 3.19% in 2023, then fell by -18bps to 3.76% in 2024, then dropped by -29bps to 4.84% in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Return on Capital Employed are 4.84% (Q4 2025), 5.47% (Q3 2025), and 5.09% (Q2 2025).